In vitro activity of BMY-28142 in comparison with those of other beta-lactam antimicrobial agents.

The in vitro susceptibility of 406 clinical isolates to BMY-28142, a new semisynthetic cephem, was evaluated and compared with cefpimizole, HR 810, ceftazidime, cefotaxime, moxalactam, and cefoperazone in a broth microdilution assay. On a weight basis, the activity of BMY-28142 against Escherichia c...

Full description

Saved in:
Bibliographic Details
Main Authors: Tsuji, A, Maniatis, A, Bertram, M A, Young, L S
Format: Artigo
Language:Inglês
Published: 1985
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC180087/
https://ncbi.nlm.nih.gov/pubmed/3839120
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items